Singapore, Oct. 23 -- Avance Clinical, the Australia-based global CRO partner for biotechs, has announced the launch of its dedicated Early Phase Centre of Excellence (CoE) for Biotechs, designed to deliver scientific rigor, innovative trial design, global regulatory insight, and operational excellence for smarter, more efficient early phase trials with significant cost savings for global biotechs.

The CoE solves the challenges facing early phase biotechs, including approval delays, slow site activation, and inefficient trial designs that drive up costs and compromise data quality. As a dedicated biotech accelerator, the center designs strategic and scalable programs that move seamlessly from pre-clinical through Phase I, into global exp...